GEDBX — GMO Emerging Markets Select Equity Fund
Data updated: 2023-10-27
GEDBX — GMO Emerging Markets Select Equity Fund. Money Market · $67.20M AUM · 0.91% expense ratio. Holdings, fees, performance and SEC filings.
GEDBX Fund Overview
GEDBX — GMO Emerging Markets Select Equity Fund is a US mutual fund managed by Gmo Trust, categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Gmo Trust
- Category: Money Market
- Assets under management: $67.20M
- 1-year return: 3.3%
- Ticker: GEDBX
- SEC CIK: 0000772129
- SEC series ID: S000029579
- Share class ID: C000213391
GEDBX Investment Objective and Strategy
GMO Emerging Markets Select Equity Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Gmo Trust.
Investment objective
Total return.
Principal investment strategy
"The Fund typically invests directly and indirectly (e.g., through underlying funds or derivatives) in equities of companies whose prospects are linked to the internal (""domestic"") development and growth of the world's non-developed markets (""emerging markets""), including companies that provide goods and services to emerging market consumers. ""Emerging markets"" include all markets that are not treated as ""developed markets"" in the MSCI World Index or MSCI EAFE Index. The term ""equities"" refers to direct and indirect investments in common and preferred stocks and other stock-related securities, such as convertible securities, depositary receipts, and equity real estate investment trusts (REITs) and income trusts. Under normal circumstances, the Fund invests directly and indirectly at least 80% of its assets in investments related to emerging markets (see ""Name Policies"").
The Fund's investments are not limited to investments in companies located in any particular country or geographic region, and often include investments in companies located in developed markets (e.g., the United States) that are related to, or whose prospects are linked to, emerging markets. GMO does not manage the Fund to, or control the Fund's risk relative to, any securities index or securities benchmark. GMO primarily uses fundamental analysis to evaluate and select countries, sectors, and companies that it believes are likely to benefit from domestic growth in emerging markets. The process begins with country and sector allocation and then focuses on the selection of individual companies. In evaluating and selecting investments, GMO may consider many factors, including, among others, GMO's assessment of a country's and/or sector's fundamentals or growth prospects as well as a company's positioning relative to its competitors.
In constructing the Fund's portfolio, GMO considers a number of factors, including the trade-off among forecasted returns, risk, transaction costs, and liquidity. At times, the Fund may have substantial exposure to a single asset class, industry, sector, country, region, or currency. The factors GMO considers and investment methods GMO uses can change over time. The Fund may invest in securities of companies of any market capitalization. The Fund also may invest in fixed income securities of any credit quality (including below investment grade securities (commonly referred to as ""junk bonds"")). As an alternative to investing directly in equities and fixed income securities, the Fund may invest in exchange-traded and over-the-counter (OTC) derivatives and exchange-traded funds (ETFs). The Fund also may invest in derivatives and ETFs in an attempt to obtain or adjust elements of its long or short investment exposure, and as a substitute for securities lending.
Derivatives used may include options, futures, forward currency contracts, warrants, swap contracts, and reverse repurchase agreements. The Fund's foreign currency exposure may differ from the currency exposure represented by its equity investments. In addition, the Fund may lend its portfolio securities. The Fund also may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds."
GEDBX Holdings
Top 10 holdings of GMO Emerging Markets Select Equity Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Taiwan Semiconductor Manufacturing Co Ltd | 10.84% |
| Samsung Electronics Co Ltd | 5.88% |
| Alibaba Group Holding Ltd | 3.43% |
| Tencent Holdings Ltd | 2.54% |
| Bank for Foreign Trade of Vietnam JSC | 2.11% |
| Kweichow Moutai Co Ltd | 2.07% |
| Delta Electronics Inc | 1.99% |
| Wal-Mart de Mexico SAB de CV | 1.87% |
| ICICI Bank Ltd | 1.80% |
| Bank Central Asia Tbk PT | 1.75% |
GEDBX Portfolio Allocation
Asset-class allocation of GMO Emerging Markets Select Equity Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 92.0% |
| Cash & Equivalents | 0.3% |
GEDBX Performance
Total returns for GEDBX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 3.3% |
| 3 years (annualised) | -11.9% |
GEDBX Risk Information
Risk metrics for GEDBX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 23.7%
GEDBX Costs and Fees
GEDBX costs about $91 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.91%
- Gross expense ratio: 1.14%
- Portfolio turnover: 143%
- Brokerage commissions: 29.98 bps of average net assets (SEC N-CEN)
GEDBX Cashflows
Over the 12 months to 2023-08, GMO Emerging Markets Select Equity Fund had net outflows of $91.84M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2023-08 | −$2.45M |
| 2023-07 | $194.00K |
| 2023-06 | $110.00K |
| 2023-05 | $18.11M |
| 2023-04 | −$52.73M |
| 2023-03 | −$26.31M |
GEDBX Debt Constituents
No individual debt constituents are reported in GMO Emerging Markets Select Equity Fund's latest SEC N-PORT filing.
GEDBX Prospectus and SEC Filings
Official GMO Emerging Markets Select Equity Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2022-06-30
- Prospectus supplement (497) — filed 2023-07-03
- Prospectus supplement (497) — filed 2022-10-26
- Portfolio holdings (N-PORT) — filed 2023-10-27
- Portfolio holdings (N-PORT) — filed 2023-07-31
- Portfolio holdings (N-PORT) — filed 2023-04-27
- Annual census (N-CEN) — filed 2023-05-12
- Annual census (N-CEN) — filed 2022-05-10
Related Funds
Other Money Market funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.